The multivariate cox proportional hazards regression model (Table 2) demonstrated a higher risk for VTE in ALK-positive NSCLC as compared with ALK-negative NSCLC (HR 1.87 [95% CI, 1.31-2.68]). This evidence concerns the gene ALK and non-small cell lung carcinoma.